BR0212834A - Formulações e uso das mesmas - Google Patents

Formulações e uso das mesmas

Info

Publication number
BR0212834A
BR0212834A BR0212834-9A BR0212834A BR0212834A BR 0212834 A BR0212834 A BR 0212834A BR 0212834 A BR0212834 A BR 0212834A BR 0212834 A BR0212834 A BR 0212834A
Authority
BR
Brazil
Prior art keywords
formulations
compositions
nicotine
chocolate
making
Prior art date
Application number
BR0212834-9A
Other languages
English (en)
Inventor
Tomas Landh
Nils-Olof Lindberg
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of BR0212834A publication Critical patent/BR0212834A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/426—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins or antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Food Science & Technology (AREA)
  • Psychology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"FORMULAçõES E USO DAS MESMAS". Descreve-se composições farmacêuticas contendo nicotina que compreendem chocolate, processo para fabricar as composições e uso das composições em diferentes terapias, tal como terapia de substituição de nicotina.
BR0212834-9A 2001-09-27 2002-09-10 Formulações e uso das mesmas BR0212834A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0103210A SE0103210D0 (sv) 2001-09-27 2001-09-27 New formulations and use thereof
PCT/SE2002/001612 WO2003026656A1 (en) 2001-09-27 2002-09-10 New formulations and use thereof

Publications (1)

Publication Number Publication Date
BR0212834A true BR0212834A (pt) 2004-10-13

Family

ID=20285456

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0212834-9A BR0212834A (pt) 2001-09-27 2002-09-10 Formulações e uso das mesmas

Country Status (19)

Country Link
EP (1) EP1429770B1 (pt)
JP (1) JP4262094B2 (pt)
KR (1) KR20040047868A (pt)
CN (1) CN1561213A (pt)
AR (1) AR036679A1 (pt)
AT (1) ATE431144T1 (pt)
AU (1) AU2002334523B2 (pt)
BR (1) BR0212834A (pt)
CA (1) CA2461757C (pt)
DE (1) DE60232344D1 (pt)
DK (1) DK1429770T3 (pt)
ES (1) ES2325684T3 (pt)
IL (1) IL160886A0 (pt)
MX (1) MXPA04002876A (pt)
NZ (1) NZ532528A (pt)
RU (1) RU2282447C2 (pt)
SE (1) SE0103210D0 (pt)
WO (1) WO2003026656A1 (pt)
ZA (1) ZA200402091B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
CN104397869B (zh) 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
RU2320674C1 (ru) * 2006-07-12 2008-03-27 Каш Тенгис Способ получения сополимера n-винилпирролидона с лаурилметакрилатом для трансдермального введения никотина, сополимер, полученный этим способом, гель для трансдермального введения никотина
CZ200980A3 (cs) * 2009-02-11 2010-04-28 Heglund A.S. Kompozice urcená k bukální absorpci nikotinu za úcelem odvykání kourení
RU2453754C1 (ru) * 2010-12-27 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования Сибирский федеральный университет (СФУ) Устройство для бестраншейной замены трубопроводов
RU2448573C1 (ru) * 2010-12-27 2012-04-27 Олег Иванович Квасенков Способ получения некурительного изделия из махорки

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8404808L (sv) * 1983-10-03 1985-04-04 Avner Rotman Mikrokapslat lekemedel i sot matris
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
SE9803986D0 (sv) * 1998-11-23 1998-11-23 Pharmacia & Upjohn Ab New compositions
SE0103211D0 (sv) * 2001-09-27 2001-09-27 Pharmacia Ab New formulations and use thereof

Also Published As

Publication number Publication date
AR036679A1 (es) 2004-09-29
RU2282447C2 (ru) 2006-08-27
JP2005503429A (ja) 2005-02-03
AU2002334523B2 (en) 2007-02-15
ES2325684T3 (es) 2009-09-14
DK1429770T3 (da) 2009-08-03
ATE431144T1 (de) 2009-05-15
CA2461757C (en) 2008-09-02
KR20040047868A (ko) 2004-06-05
JP4262094B2 (ja) 2009-05-13
MXPA04002876A (es) 2005-06-20
SE0103210D0 (sv) 2001-09-27
CN1561213A (zh) 2005-01-05
NZ532528A (en) 2005-10-28
DE60232344D1 (de) 2009-06-25
WO2003026656A1 (en) 2003-04-03
EP1429770B1 (en) 2009-05-13
RU2004108853A (ru) 2005-04-20
IL160886A0 (en) 2004-08-31
CA2461757A1 (en) 2003-04-03
ZA200402091B (en) 2005-06-29
EP1429770A1 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
BR0212857A (pt) Formulações e uso destas
ATE556706T1 (de) Fettalkohol-arzneimittel-konjugate
TR200002355T2 (tr) 2-(Pürin-9-il)tetrahidrofüran-3,4-diol türevleri
DE60045394D1 (de) Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
DK1036058T3 (da) Adamantanderivater
DE69808130D1 (de) Adamantan-derivate
BR0207760A (pt) Composição farmacêutica, uso da mesma, métodos para o tratamento de dor e de inflamação, e, processo para a preparação de uma composição
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
TR200100054T2 (tr) Paroksetin metansülfonat
IL146125A0 (en) Novel quinones as disease therapies
DE69916486D1 (de) Nicotin enthaltende pharmazeutische zusammensetzungen mit schneller transmukosaler absorption
UA66861C2 (uk) 2-феніл-1-[4-(2-аміноетокси)бензил]індол в комбінації з естрогенами, способи лікування та продукт для лікування
IL151628A0 (en) Combination therapies with vascular damaging activity
ID18079A (id) Komposisi farmasi yang mengandung bahan pemercepat osteogenesis
DK0482097T3 (da) Tensidpræparater og fremgangsmåder
ES2132556T3 (es) Nuevo derivado de benzo-tiadiazina, su procedimiento de preparacion y las composiciones farmaceuticas que lo contienen.
ATE139226T1 (de) Aminosulfonylharnstoff-acat-inhibitoren
TR200200278T2 (tr) Kalsilitik bileşimler
SE0103210D0 (sv) New formulations and use thereof
TR199901385T2 (xx) Piperidin t�revleri.
SE9803107D0 (sv) Novel Compunds
PT1232173E (pt) Derivados do acido fusidico
MEP39708A (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
SE9803158D0 (sv) A new composition

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: PFIZER HEALTH AB (SE)

Free format text: ALTERADO DE: PHARMACIA AB

B25A Requested transfer of rights approved

Owner name: MCNEIL AB (SE)

Free format text: TRANSFERIDO DE: PFIZER HEALTH AB

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA INT.CL: A61K 47/02, A61K 47/12, A61K 47/16, A61K 47/24. A61K 47/44, A61K 31/4439, A61K 31/465, A61P 25/14, A61P 25/16, A61P 25/28, A61P 2534

Ipc: A61K 31/465 (2011.01), A61K 9/20 (2011.01), A61K 9

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07F Notification of approval that there is no relation to art. 229 of lpi (pipeline patents) [chapter 7.6 patent gazette]

Free format text: NOTIFICACAO DE NAO ANUENCIA RELACIONADA COM O ART. 229 DA LPI

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.